PDCD1 and acute myeloid leukemia: Investigations explored combining anti‐PD‐1/anti‐PD‐L1 therapies with nanomaterials in the context of ferroptosis, introducing novel treatments for acute myeloid leukaemia (AML), a range of heterogeneous myeloid malignancies.95